Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
Boehringer Ingelheim

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,344,840

« Back to Dashboard

Summary for Patent: 5,344,840

Title: 4-substituted imidazole derivatives useful in perioperative care
Abstract:4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole, known as medetomidine, and in particular its d-enantiomer and salts thereof are useful in perioperative care, in particular in reducing the amount of anaesthetic it is necessary to administer.
Inventor(s): Maze; Mervyn (Portola Valley, CA), Scheinin; Mika (Naantali, FI)
Assignee: Orion-Yhtyma OY (Turku, FI)
Application Number:08/003,681
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 5,344,840

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8804683Feb 29, 1988

International Patent Family for Patent: 5,344,840

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany68913054► Subscribe
United Kingdom8804683► Subscribe
Denmark46489► Subscribe
Denmark175282► Subscribe
European Patent Office0331374► Subscribe
Canada1338556► Subscribe
Australia611262► Subscribe
Australia3027289► Subscribe
Austria101514► Subscribe
United Kingdom2215206► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus